|Assessment Status||Rapid Review Complete|
|Drug||Magnesium Aspartate Dihydrate|
|Indication||For the treatment and prevention of magnesium deficiency as diagnosed by a doctor. Magnaspartate is indicated in adults, children and adolescents aged from 2 years.|
|Rapid review commissioned||27/02/2019|
|Rapid review completed||14/05/2019|
|Rapid review outcome||A full HTA is not recommended. The NCPE recommends that magnesium aspartate dihydrate not be considered for reimbursement at the submitted price.|
This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods Act) 2013.